Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

UltraSound Guided Distal Radial Artery vS Conventional Transradial Access for Interventional Coronary Angiography (US-DRASTIC)

24 maggio 2026 aggiornato da: Grigorios Tsigkas, University Hospital of Patras
Comparative study of ultrasound-guided distal radial access versus conventional radial access regarding the incidence of vascular access crossover.

Panoramica dello studio

Descrizione dettagliata

Current European and American guidelines issued by the European Society of Cardiology (ESC), the American Heart Association (AHA), and the Society for Cardiovascular Angiography and Interventions (SCAI) recommend transradial access (TRA) as the preferred access route for cardiac catheterization in both acute and chronic coronary syndromes, as well as in complex coronary interventions. Compared with transfemoral access, transradial access has demonstrated significant benefits regarding vascular complications, major bleeding, mortality, and earlier mobilization and discharge of patients.

In recent years, access through the distal segment of the radial artery in the anatomical snuffbox has emerged as a technique with highly beneficial characteristics comparable to conventional radial access, while also offering additional advantages. The ANGIE study demonstrated that distal radial access was associated with a statistically significant reduction in radial artery occlusion compared with conventional radial puncture. Puncture of the distal radial artery preserves antegrade blood flow in the forearm during hemostatic compression, thereby reducing the risk of arterial occlusion.

Existing literature Although the benefit of distal radial access in preventing radial artery occlusion has now been established, the same does not apply to crossover incidence, namely the need to change to an alternative vascular access site because the intervention cannot be completed through the initially selected access.

Several studies have shown higher crossover rates with distal radial access compared with conventional radial access. In the study by Koutouzis et al., distal radial access failed more often, with a crossover incidence of 30% versus 2% in the conventional radial group. Similar findings were reported in the DAPRAO study, the ANGIE trial, the DISCO RADIAL trial, the CONDITION trial, and observational studies and meta-analyses. Overall, published evidence consistently suggests that distal radial access is associated with a higher likelihood of crossover than conventional radial access when performed without ultrasound guidance.

Aim and originality of the study A common characteristic of all the above studies is that the comparison between the two access techniques was performed using anatomical guidance rather than ultrasound guidance.

As noted in the SCAI recommendations, failure to catheterize the radial artery is the leading cause of transradial procedural failure. The radial artery is relatively small in diameter, may be calcified, or may present anatomical variations that complicate vascular access. Two-dimensional ultrasound may therefore be a valuable tool for pre-procedural planning and real-time guidance.

A large meta-analysis of 12 studies including 2,432 adults undergoing conventional transradial access under ultrasound guidance showed improved first-pass success rates and reduced access failure rates. Similarly, ultrasound-guided distal radial access significantly increased successful intervention rates in the study by Mori et al. Consequently, the purpose of the present study is to demonstrate ultrasound guidance as a technique capable of increasing successful completion rates for both vascular approaches, while establishing distal radial access as a non-inferior alternative to conventional radial access regarding crossover probability.

Methodology The study will be conducted after approval by the Scientific Council and the Ethics and Deontology Committee of the University General Hospital of Patras.

This is a prospective, randomized, single-center, non-inferiority clinical study that will be carried out in the Hemodynamic Laboratory of the Cardiology Department of the University General Hospital of Patras in collaboration with the Radiology Department.

Study population The control group will undergo coronary angiography through conventional transradial access (TRA). The intervention group will undergo coronary angiography through distal radial access (DRA). Radial artery puncture will be performed exclusively under ultrasound guidance. Patients meeting the inclusion criteria and none of the exclusion criteria will be randomized in a 1:1 ratio to DRA or TRA.

Arterial access procedure:

The procedure begins with sterilization of both potential puncture sites regardless of randomization group. Conventional radial artery puncture is performed approximately 2-3 cm proximal to the styloid process. In patients randomized to distal transradial access (dTRA), puncture is performed more distally in the anatomical snuffbox at an angle of 30-80 degrees.

The interventional cardiologist uses the ultrasound probe exclusively, covered with a sterile protective sheath, to identify anatomical landmarks, define a safe puncture site, and avoid injury to adjacent structures. Local lidocaine infiltration is then performed under ultrasound guidance. The intravascular position of the needle is confirmed by ultrasound visualization and continuous blood flow.

After successful puncture of the radial artery, a 6 French sheath is inserted using the Seldinger technique. Subsequently, 50 IU/kg unfractionated heparin is administered (100 IU/kg total dose in case of angioplasty), together with nitroglycerin according to standard practice.

Hemostasis procedure After completion of the procedure, a TR band device is used. Hemostasis is assessed at 0,5 ,1, 2, and 3 hours after placement of the device, and if hemostasis is not achieved within this timeframe, manual compression is applied.

Data collection

For all participants, the following will be recorded:

  • Demographic characteristics, cardiovascular risk factors, medical history, and chronic medication
  • Body weight and body mass index (BMI)
  • Reason for catheterization (STEMI, NSTEMI, unstable angina, stable coronary artery disease, suspected coronary artery disease, or valvular disease)
  • Periprocedural antiplatelet or anticoagulant therapy
  • Laboratory tests: Ht, Hgb, PLT, WBC, Urea, Creatinine
  • Allen test and quality of radial artery pulse
  • Total puncture attempts and total time to achieve vascular access
  • Fluoroscopy duration, total angiography time, and contrast volume
  • Number and type of diagnostic catheters used
  • Type of hemostatic device and duration of hemostasis Primary endpoint Need for vascular access crossover due to failed puncture, failed wire or sheath advancement, or inability to complete the procedure through the initial vascular access. The exact reason for crossover will be recorded.

Secondary endpoints

  • Local hematoma classified according to EASY criteria
  • Arterial spasm severity
  • Sheath placement time
  • Total procedural time
  • Time from puncture initiation until completion of coronary angiography before PCI
  • Time required for diagnostic coronary angiography after sheath placement
  • Time required until PCI completion
  • Total fluoroscopy time
  • Total DAP
  • Air Kerma
  • Hemostasis duration
  • Vascular complications (arterial perforation, pseudoaneurysm, arteriovenous fistula)
  • Distal radial artery occlusion before discharge
  • Bleeding events according to BARC classification

Tipo di studio

Interventistico

Iscrizione (Stimato)

1400

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Athinagoras Theofilatos
  • Numero di telefono: +30 6946747300
  • Email: athinag@gmail.com

Backup dei contatti dello studio

  • Nome: Grigorios Tsigas, assistant professor
  • Numero di telefono: +30 6974466662

Luoghi di studio

      • Pátrai, Grecia
        • Reclutamento
        • University Hospital of Patras
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Indication for Invasive coronary angiography

Exclusion Criteria:

  • STEMI
  • Renal replacement therapy patients
  • Serious dermal or bone deformity of the radiocarpal joint
  • Shock

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore attivo: ultrasound guided distal radial artery
ultrasound guided distal radial artery acess for coronary angiography
Diagnostic and if indicated percutaneus coronary intervention during coronary angiography
Altri nomi:
  • pci
Comparatore attivo: ultrasound guided conventional transradial acess
ultrasound guided conventional transradial acess for coronary angiography
Diagnostic and if indicated percutaneus coronary intervention during coronary angiography
Altri nomi:
  • pci

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
crossover
Lasso di tempo: Periprocedural.Up to 5 mins will be allowed before giving up on designated method to obtain access
Need for a different access to begin the procedure other than the one specified in the patient's arm
Periprocedural.Up to 5 mins will be allowed before giving up on designated method to obtain access

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Arterial vasospasm
Lasso di tempo: periprocedural
periprocedural
hemostasis
Lasso di tempo: Will be checked at set intervals of 30-60-90-180 mins post procedure
Time from procedure's end until removal of hemostatic device
Will be checked at set intervals of 30-60-90-180 mins post procedure
Time until pci
Lasso di tempo: periprocedural
Time from first needle puncture until pci (percutaneous coronary intervention) has been completed (If needed)
periprocedural
radial artery occlusion
Lasso di tempo: 30 days post procedure
ultrasound evaluation of radial artery patency after end of hemostasis
30 days post procedure
hematoma
Lasso di tempo: pre discharge , post procedure
using EASY classification
pre discharge , post procedure
Time required for sheath insertion
Lasso di tempo: periprocedural
Time required from first puncture until sheath is sucessfully introduced into the artery
periprocedural
Total procedure time
Lasso di tempo: periprocedural
Time from first needle puncture until procedure end (hemostatic device placement signals the end )
periprocedural
Coronary angiography time
Lasso di tempo: periprocedural
Time from first needle puncture until all 3 coronary arteries have been sufficiently depicted
periprocedural

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

12 maggio 2026

Completamento primario (Stimato)

12 maggio 2028

Completamento dello studio (Stimato)

1 novembre 2028

Date di iscrizione allo studio

Primo inviato

12 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

24 maggio 2026

Primo Inserito (Effettivo)

1 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

1 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

24 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Descrizione del piano IPD

We plan to share data with other researchers only if they're formally requested and cited afterwards

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su coronary angiography

Sottoscrivi